e-learning
resources
Virtual 2021
08.09.2021
Pearls in asthma and respiratory burden research
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Blood inflammatory phenotypes of asthma in the Constances cohort
T. TSIAVIA (VILLEJUIF, France), J. Henny (VILLEJUIF, France), M. Goldberg (VILLEJUIF, France), M. Zins (VILLEJUIF, France), N. Roche (PARIS, France), L. Orsi* (VILLEJUIF, France), R. Nadif* (VILLEJUIF, France)
Source:
Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Session:
Pearls in asthma and respiratory burden research
Session type:
Oral Presentation
Number:
4217
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. TSIAVIA (VILLEJUIF, France), J. Henny (VILLEJUIF, France), M. Goldberg (VILLEJUIF, France), M. Zins (VILLEJUIF, France), N. Roche (PARIS, France), L. Orsi* (VILLEJUIF, France), R. Nadif* (VILLEJUIF, France). Blood inflammatory phenotypes of asthma in the Constances cohort. 4217
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Blood biomarkers in asthma and COPD
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017
Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study
Source: Eur Respir J 2016; 48: 1040-1051
Year: 2016
Characteristics of children with asthma and blood eosinophilia: an observational study
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021
Sputum induction elicits different peripheral airways responses in healthy subjects, asthma and allergic rhinitis patients
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Blood inflammatory patterns and dyspnea in asthmatics from the EGEA study: cross-sectional and longitudinal analyses
Source: Annual Congress 2007 - Risk factors for prevalence and incidence of asthma
Year: 2007
Identifying systemic inflammatory markers in the Melbourne COPD exacerbation cohort
Source: Eur Respir J 2005; 26: Suppl. 49, 51s
Year: 2005
Study of the inflammatory phenotype of asthmatic patients with bronchiectasis
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes
Source: Eur Respir J 2015; 46: 688-696
Year: 2015
Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020
Blood neutrophil pattern is associated with poor asthma control in adults from the EGEA study
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015
Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Serial blood eosinophils and clinical characteristics in COPD patients without a history of asthma or atopy
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019
Cytokines profile of blood and sputum in COPD exacerbation
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Cytokines profile of blood and sputum in COPD exacerbation
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept